Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Current Studies at Motherisk: Lamisil in Pregnancy
Motherisk is currently conducting a study to determine the safety of Lamisil (terbinafine) use in pregnancy. This is prescribed for the treatment of fungal infections of the toenail, fingernail and various skin infections. The primary objective of this study is to evaluate the risk for major malformations and other adverse fetal effects following exposure to this medication.
If you are currently pregnant and exposed to Lamisil at any point during the pregnancy, please contact Moumita Sarkar at 1-800-670-6126 or by e-mail. Your participation will involve a follow-up by telephone interview at 6 months after delivery. All calls are strictly confidential.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)